Severe COPD: Multidisciplinary Consultation to Get the Right Care at the Right Place

Click to increase image sizeClick to decrease image size

Acknowledgments

Participants of Severe Asthma & COPD Network South West Netherlands, besides authors of this research letter:

Esther Vis, MD – Department of Pulmonary medicine, Admiraal de Ruiter ziekenhuis

Chantal Kroese, MD – Department of Pulmonary medicine, Ikazia, Rotterdam, the Netherlands

Stephanie van Loon-Kooij, MD – Department of Pulmonary medicine, Reinier de Graaf ziekenhuis, Delft, the Netherlands

Jeroen van Exsel, MD – Department of Pulmonary medicine, HAGA, Den Haag, the Netherlands

Dennis van Leeuwen, MD – Department of Pulmonary medicine, Spijkenisse Medisch centrum, Spijkenisse, the Netherlands

Jasmijn van Kampen, MD – Department of Pulmonary medicine, MC Haaglanden, Den Haag, the Netherlands

Maurice Jans, MD – Department of Pulmonary medicine, Rivas Beatrixziekenhuis, Gorinchem, the Netherlands

Jelmer Vahl, MD – Department of Pulmonary medicine, Ijsselland ziekenhuis, Capelle aan den IJssel

Remco Djamin, MD – Department of Pulmonary medicine, Amphia ziekenhuis, Breda, the Netherlands

Jacobine Herbrink, MD – Department of Pulmonary medicine, Het van Weel-Bethesda ziekenhuis, Dirksland, the Netherlands

Wouter Blox, MD – Department of Pulmonary medicine, Albert Schweitzer ziekenhuis, Dordrecht, the Netherlands

Jeroen Retera, MD – Department of Pulmonary medicine, Elisabeth-TweeSteden ziekenhuis, Tilburg, the Netherlands

Yordi van Dooren, MD – Department of Pulmonary medicine, Groene Hart ziekenhuis, Gouda, the Netherlands

Disclosure

Dr Gert-Jan Braunstahl reports grants and/or personal fees from GSK, Sanofi, AstraZeneca, ALKAbello, outside the submitted work. Dr Johannes In ‘t Veen reports Unrestricted grant to institution from Teva, Astra Zeneca, Chiesi; Speaker Bureau for Sanofi, Chiesi, GSK, Astra Zeneca, Health Investment, StichtingRoLeX. The authors report no other conflicts of interest in this work.